missing translation for 'onlineSavingsMsg'
Learn More

CD14 (Monocyte / Macrophage Marker) Mouse, Clone: LPSR/2385, enQuireBio™

Mouse Monoclonal Antibody

199.00 EUR - 478.00 EUR

Specifications

Antigen CD14 (Monocyte / Macrophage Marker)
Clone LPSR/2385
Concentration 200μg/mL
Applications Immunohistochemistry
Classification Monoclonal
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
15921188
View Documents
EnquireBio
929-MSM5-P0
20 μg This item is currently unavailable or has been discontinued.
View the product page for possible alternatives.
N/A View alternative products
Save Up to 
»
15931188
View Documents
EnquireBio
929-MSM5-P1
100 μg
ONLINE EXCLUSIVE PRICE
554.40 EUR
478.00 EUR / 100µg
Save 76.40 EUR
13% Off
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

Specifications

Specifications

CD14 (Monocyte / Macrophage Marker)
200μg/mL
Monoclonal
Mouse
10mM PBS with 0.05% BSA and 0.05% azide. Also available without BSA and Azide.
Recombinant fragment of human CD14 protein (apprx. aa 25-148)
Primary
Short term: Store at 2-4°C. Long term, aliquot and store at -20°C.
55kDa
LPSR/2385
Immunohistochemistry
Unconjugated
RUO
929
IgG1 κ
Protein A/G purified from Bioreactor concentrate.
Cell Surface
THP-1 cells and human monocytes. Lymph nodes and tonsils.
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.